Response-Adaptive Treatment in Untreated Locoregional HPV-Negative Head and Neck Cancer

NCT07065630 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

38

Enrollment

OTHER

Sponsor class

Conditions

Head and Neck Cancer
HPV

Interventions

DRUG: Volrustomig
DRUG: Carboplatin
DRUG: Paclitaxel

Sponsor

University of Chicago